Table 1.

Distribution of the Patients Among the Different SCID Subgroups Before and After Haploidentical BMT

No. of Patients Alive With Donor T-Cell Engraftment at 6 Mo Post-BMT Alive at Last Follow-Up (median, 6 yr)
Absence of T lymphocytes B+ SCID  107  71 62  
Absence of T and B lymphocytes B− SCID  50  24 15  
Adenosine deaminase deficiency  20  12  8  
Other types of SCID  10  5  5  
Reticular dysgenesis  6  2  
Total  193  116  92 
No. of Patients Alive With Donor T-Cell Engraftment at 6 Mo Post-BMT Alive at Last Follow-Up (median, 6 yr)
Absence of T lymphocytes B+ SCID  107  71 62  
Absence of T and B lymphocytes B− SCID  50  24 15  
Adenosine deaminase deficiency  20  12  8  
Other types of SCID  10  5  5  
Reticular dysgenesis  6  2  
Total  193  116  92 
Close Modal

or Create an Account

Close Modal
Close Modal